Change search
ReferencesLink to record
Permanent link

Direct link
Serum glucose and risk of cancer: a meta-analysis
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Surgical Sciences, Endocrine Surgery.
Show others and affiliations
2014 (English)In: BMC Cancer, ISSN 1471-2407, Vol. 14, 985Article in journal (Refereed) Published
Abstract [en]

Background: Raised serum glucose has been linked to increased risk of many solid cancers. We performed a meta-analysis to quantify and summarise the evidence for this link. Methods: Pubmed and Embase were reviewed, using search terms representing serum glucose and cancer. Inclusion and exclusion criteria focused on epidemiological studies with clear definitions of serum glucose levels, cancer type, as well as well-described statistical methods with sufficient data available. We used 6.1 mmol/L as the cut-off for high glucose, consistent with the WHO definition of metabolic syndrome. Random effects analyses were performed to estimate the pooled relative risk (RR). Results: Nineteen studies were included in the primary analysis, which showed a pooled RR of 1.32 (95% CI: 1.20 - 1.45). Including only those individuals with fasting glucose measurements did not have a large effect on the pooled RR (1.32 (95% CI: 1.11-1.57). A stratified analysis showed a pooled RR of 1.34 (95% CI: 1.02-1.77) for hormonally driven cancer and 1.21 (95% CI: 1.09-1.36) for cancers thought to be driven by Insulin Growth Factor-1. Conclusion: A positive association between serum glucose and risk of cancer was found. The underlying biological mechanisms remain to be elucidated but our subgroup analyses suggest that the insulin- IGF-1 axis does not fully explain the association. These findings are of public health importance as measures to reduce serum glucose via lifestyle and dietary changes could be implemented in the context of cancer mortality.

Place, publisher, year, edition, pages
2014. Vol. 14, 985
Keyword [en]
Glucose, Cancer, Metabolic syndrome, Meta-analysis, Diabetes
National Category
Cancer and Oncology
URN: urn:nbn:se:uu:diva-245533DOI: 10.1186/1471-2407-14-985ISI: 000347964700001PubMedID: 25526881OAI: diva2:793925
Available from: 2015-03-09 Created: 2015-02-26 Last updated: 2015-03-09Bibliographically approved

Open Access in DiVA

fulltext(962 kB)72 downloads
File information
File name FULLTEXT01.pdfFile size 962 kBChecksum SHA-512
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Holmberg, Lars
By organisation
Endocrine Surgery
In the same journal
BMC Cancer
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar
Total: 72 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 287 hits
ReferencesLink to record
Permanent link

Direct link